Flynn James E

13D and 13G Filings

13D/G filings: 13D on 6 securities, 13G on 27 securities
CIK: 0001352546
All SEC filings: View on sec.gov

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Climb Bio, Inc. 13G CLYM · 28658R106	CLYM	28658R106	5.3%	3,070,000	13G	10/28/2026 Event 10/27/2026
Deerfield Mgmt, L.P.			5.3%	3,070,000
Deerfield Management Company, L.P.			5.3%	3,070,000
Deerfield Partners, L.P.			5.3%	3,070,000
James E. Flynn			5.3%	3,070,000
Enhabit, Inc. 13G/A Amendment 3 EHAB · 29332G102	EHAB	29332G102	0%	0	13G/A Amendment 3	8/13/2026 Event 6/30/2026
Deerfield Mgmt, L.P.			0%	0
Deerfield Management Company, L.P.			0%	0
Deerfield Partners, L.P.			0%	0
James E. Flynn			0%	0
Cogent Biosciences, Inc. 13G/A Amendment 2 COGT · 19240Q201	COGT	19240Q201	2.9%	5,006,104	13G/A Amendment 2	8/13/2026 Event 6/30/2026
Deerfield Mgmt, L.P.			2.9%	5,006,104
Deerfield Management Company, L.P.			2.9%	5,006,104
Deerfield Partners, L.P.			2.9%	5,006,104
James E. Flynn			2.9%	5,006,104
Nuvalent, Inc. 13G/A Amendment 7 NUVL · 670703107	NUVL	670703107	0%	0	13G/A Amendment 7	7/17/2026 Event 7/15/2026
Deerfield Management Company, L.P.			0%	0
Deerfield Mgmt IV, L.P.			0%	0
Deerfield Private Design Fund IV, L.P.			0%	0
Deerfield Mgmt HIF, L.P.			0%	0
Deerfield Healthcare Innovations Fund, L.P.			0%	0
Deerfield Mgmt, L.P.			0%	0
Deerfield Partners, L.P.			0%	0
James E. Flynn			0%	0
BiomX Inc. 13D/A Amendment 7 PHGE · 09090D509	PHGE	09090D509	4.7%	533,370	13D/A Amendment 7	6/16/2026 Event 6/12/2026
Deerfield Private Design Fund V, L.P.			2.4%	266,424
Deerfield Mgmt V, L.P.			2.4%	266,424
Deerfield Healthcare Innovations Fund II, L.P.			2.4%	266,424
Deerfield Mgmt HIF II, L.P.			2.4%	266,424
Deerfield Management Company, L.P.			4.7%	533,370
James E. Flynn			4.7%	533,370
BiomX Inc. 13D/A Amendment 6 PHGE · 09090D509	PHGE	09090D509	8.1%	889,928	13D/A Amendment 6	5/28/2026 Event 5/26/2026
Deerfield Private Design Fund V, L.P.			4.1%	444,703
Deerfield Mgmt V, L.P.			4.1%	444,703
Deerfield Healthcare Innovations Fund II, L.P.			4.1%	444,703
Deerfield Mgmt HIF II, L.P.			4.1%	444,703
Deerfield Management Company, L.P.			8.1%	889,928
James E. Flynn			8.1%	889,928
Inspire Medical Systems, Inc. 13G/A Amendment 1 INSP · 457730109	INSP	457730109	4.5%	1,296,862	13G/A Amendment 1	5/14/2026 Event 5/14/2026
Deerfield Mgmt, L.P.			4.5%	1,296,862
Deerfield Management Company, L.P.			4.5%	1,296,862
Deerfield Partners, L.P.			4.5%	1,296,862
James E. Flynn			4.5%	1,296,862
Cogent Biosciences, Inc. 13G/A Amendment 1 COGT · 19240Q201	COGT	19240Q201	5.3%	9,043,903	13G/A Amendment 1	5/14/2026 Event 3/31/2026
Deerfield Mgmt, L.P.			5.3%	9,043,903
Deerfield Management Company, L.P.			5.3%	9,043,903
Deerfield Partners, L.P.			5.3%	9,043,903
James E. Flynn			5.3%	9,043,903
Foghorn Therapeutics Inc. 13G/A Amendment 2 FHTX · 344174107	FHTX	344174107	8.6%	5,139,523	13G/A Amendment 2	5/14/2026 Event 3/31/2026
Deerfield Mgmt, L.P.			8.6%	5,139,523
Deerfield Management Company, L.P.			8.6%	5,139,523
Deerfield Partners, L.P.			8.6%	5,139,523
James E. Flynn			8.6%	5,139,523
BiomX Inc. 13D/A Amendment 5 PHGE · 09090D509	PHGE	09090D509	10.0%	989,056	13D/A Amendment 5	4/15/2026 Event 4/15/2026
Deerfield Private Design Fund V, L.P.			5.6%	494,267
Deerfield Mgmt V, L.P.			5.6%	494,267
Deerfield Healthcare Innovations Fund II, L.P.			5.6%	494,267
Deerfield Mgmt HIF II, L.P.			5.6%	494,267
Deerfield Management Company, L.P.			10.0%	989,056
James E. Flynn			10.0%	989,056
Larimar Therapeutics, Inc. 13D/A Amendment 11 LRMR · 517125100	LRMR	517125100	34.4%	35,667,474	13D/A Amendment 11	3/2/2026 Event 2/27/2026
Deerfield Private Design Fund III, L.P.			10.3%	10,622,928
Deerfield Healthcare Innovations Fund, L.P.			7.9%	8,153,107
Deerfield Private Design Fund IV, L.P.			10.3%	10,622,957
Deerfield Partners, L.P.			6.0%	6,207,982
Deerfield Mgmt III, L.P.			10.3%	10,622,928
Deerfield Mgmt HIF, L.P.			7.9%	8,153,107
Deerfield Mgmt IV, L.P.			10.3%	10,622,957
Deerfield Mgmt, L.P.			6.0%	6,207,982
Deerfield Management Company, L.P.			34.4%	35,667,474
James E. Flynn			34.4%	35,667,474
BioCryst Pharmaceuticals, Inc. 13G/A Amendment 1 BCRX · 09058V103	BCRX	09058V103	6.8%	14,341,000	13G/A Amendment 1	2/12/2026 Event 12/31/2025
Deerfield Mgmt, L.P.			6.8%	14,341,000
Deerfield Management Company, L.P.			6.8%	14,341,000
Deerfield Partners, L.P.			6.8%	14,341,000
James E. Flynn			6.8%	14,341,000
Nuvalent, Inc. 13G/A Amendment 6 NUVL · 670703107	NUVL	670703107	24.2%	22,852,280	13G/A Amendment 6	2/12/2026 Event 12/31/2025
Deerfield Management Company, L.P.			24.2%	22,852,280
Deerfield Mgmt IV, L.P.			11.6%	11,016,852
Deerfield Private Design Fund IV, L.P.			11.6%	11,016,852
Deerfield Mgmt HIF, L.P.			11.6%	11,016,852
Deerfield Healthcare Innovations Fund, L.P.			11.6%	11,016,852
Deerfield Mgmt, L.P.			0.9%	650,000
Deerfield Partners, L.P.			0.9%	650,000
James E. Flynn			24.2%	22,852,280
BiomX Inc. 13D/A Amendment 4 PHGE · 09090D509	PHGE	09090D509	10.0%	989,056	13D/A Amendment 4	2/11/2026 Event 2/9/2026
Deerfield Private Design Fund V, L.P.			10.0%	494,267
Deerfield Mgmt V, L.P.			10.0%	494,267
Deerfield Healthcare Innovations Fund II, L.P.			10.0%	494,267
Deerfield Mgmt HIF II, L.P.			10.0%	494,267
Deerfield Management Company, L.P.			10.0%	989,056
James E. Flynn			10.0%	989,056
CalciMedica Inc. 13G/A Amendment 1 CALC · 38942Q202	CALC	38942Q202	4.3%	653,253	13G/A Amendment 1	2/6/2026 Event 2/6/2026
Deerfield Mgmt, L.P.			4.3%	653,253
Deerfield Management Company, L.P.			4.3%	653,253
Deerfield Partners, L.P.			4.3%	653,253
James E. Flynn			4.3%	653,253
Certara, Inc. 13G/A Amendment 1 CERT · 15687V109	CERT	15687V109	4.9%	7,808,605	13G/A Amendment 1	11/25/2025 Event 11/25/2025
Deerfield Mgmt, L.P.			4.9%	7,808,605
Deerfield Management Company, L.P.			4.9%	7,808,605
Deerfield Partners, L.P.			4.9%	7,808,605
James E. Flynn			4.9%	7,808,605
Certara, Inc. 13G CERT · 15687V109	CERT	15687V109	6.3%	10,011,000	13G	11/13/2025 Event 11/7/2025
Deerfield Mgmt, L.P.			6.3%	10,011,000
Deerfield Management Company, L.P.			6.3%	10,011,000
Deerfield Partners, L.P.			6.3%	10,011,000
James E. Flynn			6.3%	10,011,000
Inspire Medical Systems, Inc. 13G INSP · 457730109	INSP	457730109	5.1%	1,476,303	13G	11/13/2025 Event 11/6/2025
Deerfield Mgmt, L.P.			5.1%	1,476,303
Deerfield Management Company, L.P.			5.1%	1,476,303
Deerfield Partners, L.P.			5.1%	1,476,303
James E. Flynn			5.1%	1,476,303
Cullinan Therapeutics, Inc. 13G/A Amendment 1 CGEM · 230031106	CGEM	230031106	4.95%	2,927,013	13G/A Amendment 1	11/13/2025 Event 9/30/2025
Deerfield Mgmt, L.P.			4.95%	2,927,013
Deerfield Management Company, L.P.			4.95%	2,927,013
Deerfield Partners, L.P.			4.95%	2,927,013
James E. Flynn			4.95%	2,927,013
Lomond Therapeutics Holdings, Inc. 13G/A Amendment 1 54173L101		54173L101	8.4%	2,692,625	13G/A Amendment 1	11/13/2025 Event 9/30/2025
Deerfield Mgmt, L.P.			8.4%	2,692,625
Deerfield Management Company, L.P.			8.4%	2,692,625
Deerfield Partners, L.P.			8.4%	2,692,625
James E. Flynn			8.4%	2,692,625
Indivior PLC 13G/A Amendment 3 INDV · G4766E116	INDV	G4766E116	3.7%	4,614,498	13G/A Amendment 3	11/13/2025 Event 11/10/2025
Deerfield Mgmt, L.P.			3.7%	4,614,498
Deerfield Management Company, L.P.			3.7%	4,614,498
Deerfield Partners, L.P.			3.7%	4,614,498
James E. Flynn			3.7%	4,614,498
Oscar Health, Inc. 13G/A Amendment 3 OSCR · 687793109	OSCR	687793109	0%	0	13G/A Amendment 3	11/13/2025 Event 9/30/2025
Deerfield Mgmt, L.P.			0%	0
Deerfield Management Company, L.P.			0%	0
Deerfield Partners, L.P.			0%	0
James E. Flynn			0%	0
AdaptHealth Corp. 13G/A Amendment 5 AHCO · 00653Q102	AHCO	00653Q102	8.5%	23,863,685	13G/A Amendment 5	11/13/2025 Event 9/30/2025
Deerfield Mgmt, L.P.			7.2%	11,544,108
Deerfield Mgmt IV, L.P.			4.9%	12,319,577
Deerfield Partners, L.P.			7.2%	11,544,108
Deerfield Private Design Fund IV, L.P.			4.9%	12,319,577
Deerfield Management Company, L.P.			8.5%	23,863,685
James E. Flynn			8.5%	23,863,685
Savara Inc. 13G SVRA · 805111101	SVRA	805111101	6.7%	13,569,000	13G	11/5/2025 Event 10/30/2025
Deerfield Mgmt, L.P.			6.7%	13,569,000
Deerfield Management Company, L.P.			6.7%	13,569,000
Deerfield Partners, L.P.			6.7%	13,569,000
James E. Flynn			6.7%	13,569,000
BioCryst Pharmaceuticals, Inc. 13G BCRX · 09058V103	BCRX	09058V103	5.8%	12,169,000	13G	9/19/2025 Event 9/12/2025
Deerfield Mgmt, L.P.			5.8%	12,169,000
Deerfield Management Company, L.P.			5.8%	12,169,000
Deerfield Partners, L.P.			5.8%	12,169,000
James E. Flynn			5.8%	12,169,000
Brookdale Senior Living Inc. 13G/A Amendment 4 BKD · 112463104	BKD	112463104	4.9%	11,637,032	13G/A Amendment 4	8/22/2025 Event 8/22/2025
Deerfield Mgmt, L.P.			4.9%	11,637,032
Deerfield Management Company, L.P.			4.9%	11,637,032
Deerfield Partners, L.P.			4.9%	11,637,032
James E. Flynn			4.9%	11,637,032
BridgeBio Oncology Therapeutics, Inc. 13G BBOT · 107924102	BBOT	107924102	6.2%	4,885,446	13G	8/18/2025 Event 8/11/2025
Deerfield Mgmt, L.P.			3.1%	2,442,723
Deerfield Mgmt V, L.P.			3.1%	2,442,723
Deerfield Partners, L.P.			3.1%	2,442,723
Deerfield Private Design Fund V, L.P.			3.1%	2,442,723
Deerfield Management Company, L.P.			6.2%	4,885,446
James E. Flynn			6.2%	4,885,446
Brookdale Senior Living Inc. 13G/A Amendment 3 BKD · 112463104	BKD	112463104	6.5%	15,362,264	13G/A Amendment 3	8/14/2025 Event 6/30/2025
Deerfield Mgmt, L.P.			6.5%	15,362,264
Deerfield Management Company, L.P.			6.5%	15,362,264
Deerfield Partners, L.P.			6.5%	15,362,264
James E. Flynn			6.5%	15,362,264
ARS Pharmaceuticals, Inc. 13D/A Amendment 5 SPRY · 82835W108	SPRY	82835W108	7.8%	7,610,217	13D/A Amendment 5	8/1/2025 Event 7/30/2025
Deerfield Mgmt III, L.P.			3.9%	3,805,108
Deerfield Private Design Fund III, L.P.			3.9%	3,805,108
Deerfield Mgmt IV, L.P.			3.9%	3,805,109
Deerfield Private Design Fund IV, L.P.			3.9%	3,805,109
Deerfield Management Company, L.P.			7.8%	7,610,217
James E. Flynn			7.8%	7,610,217
Larimar Therapeutics, Inc. 13D/A Amendment 10 LRMR · 517125100	LRMR	517125100	35.8%	30,667,474	13D/A Amendment 10	7/31/2025 Event 7/31/2025
Deerfield Private Design Fund III, L.P.			11.1%	9,538,918
Deerfield Healthcare Innovations Fund, L.P.			8.6%	7,321,129
Deerfield Private Design Fund IV, L.P.			11.1%	9,538,945
Deerfield Partners, L.P.			4.9%	4,207,982
Deerfield Mgmt III, L.P.			11.1%	9,538,918
Deerfield Mgmt HIF, L.P.			8.6%	7,321,129
Deerfield Mgmt IV, L.P.			11.1%	9,538,945
Deerfield Mgmt, L.P.			4.9%	4,207,982
Deerfield Management Company, L.P.			35.8%	30,667,474
James E. Flynn			35.8%	30,667,474
ARS Pharmaceuticals, Inc. 13D/A Amendment 4 SPRY · 82835W108	SPRY	82835W108	8.8%	8,633,537	13D/A Amendment 4	7/22/2025 Event 7/18/2025
Deerfield Mgmt III, L.P.			4.4%	4,316,768
Deerfield Private Design Fund III, L.P.			4.4%	4,316,768
Deerfield Mgmt IV, L.P.			4.4%	4,316,769
Deerfield Private Design Fund IV, L.P.			4.4%	4,316,769
Deerfield Management Company, L.P.			8.8%	8,633,537
James E. Flynn			8.8%	8,633,537
Cogent Biosciences, Inc. 13G COGT · 19240Q201	COGT	19240Q201	6.5%	9,053,118	13G	7/11/2025 Event 7/7/2025
Deerfield Mgmt, L.P.			6.5%	9,053,118
Deerfield Management Company, L.P.			6.5%	9,053,118
Deerfield Partners, L.P.			6.5%	9,053,118
James E. Flynn			6.5%	9,053,118
ARS Pharmaceuticals, Inc. 13D/A Amendment 3 SPRY · 82835W108	SPRY	82835W108	9.9%	9,724,508	13D/A Amendment 3	7/2/2025 Event 7/2/2025
Deerfield Mgmt III, L.P.			4.95%	4,862,254
Deerfield Private Design Fund III, L.P.			4.95%	4,862,254
Deerfield Mgmt IV, L.P.			4.95%	4,862,254
Deerfield Private Design Fund IV, L.P.			4.95%	4,862,254
Deerfield Management Company, L.P.			9.9%	9,724,508
James E. Flynn			9.9%	9,724,508
Vera Therapeutics, Inc. 13G VERA · 92337R101	VERA	92337R101	5.3%	3,348,117	13G	6/11/2025 Event 6/6/2025
Deerfield Mgmt, L.P.			5.3%	3,348,117
Deerfield Management Company, L.P.			5.3%	3,348,117
Deerfield Partners, L.P.			5.3%	3,348,117
James E. Flynn			5.3%	3,348,117
Owens & Minor, Inc. 13G/A Amendment 2 ACH · 690732102	ACH	690732102	0%	0	13G/A Amendment 2	5/13/2025 Event 3/31/2025
Deerfield Mgmt, L.P.			0%	0
Deerfield Management Company, L.P.			0%	0
Deerfield Partners, L.P.			0%	0
James E. Flynn			0%	0
Indivior PLC 13G/A Amendment 2 INDV · G4766E116	INDV	G4766E116	8.5%	10,567,160	13G/A Amendment 2	5/13/2025 Event 3/31/2025
Deerfield Mgmt, L.P.			8.5%	10,567,160
Deerfield Management Company, L.P.			8.5%	10,567,160
Deerfield Partners, L.P.			8.5%	10,567,160
James E. Flynn			8.5%	10,567,160
Embecta Corp. 13G/A Amendment 1 EMBC · 29082K105	EMBC	29082K105	4.7%	2,720,535	13G/A Amendment 1	5/13/2025 Event 3/31/2025
Deerfield Mgmt, L.P.			4.7%	2,720,535
Deerfield Management Company, L.P.			4.7%	2,720,535
Deerfield Partners, L.P.			4.7%	2,720,535
James E. Flynn			4.7%	2,720,535
Mallinckrodt plc 13G/A Amendment 3 MNKTQ · G5890A102	MNKTQ	G5890A102	4.1%	804,259	13G/A Amendment 3	5/13/2025 Event 3/31/2025
Deerfield Mgmt, L.P.			4.1%	804,258
Deerfield Mgmt IV, L.P.			0%	1
Deerfield Partners, L.P.			4.1%	804,258
Deerfield Private Design Fund IV, L.P.			0%	1
Deerfield Management Company, L.P.			4.1%	804,259
James E. Flynn			4.1%	804,259
ARS Pharmaceuticals, Inc. 13D/A Amendment 2 SPRY · 82835W108	SPRY	82835W108	10.7%	10,514,657	13D/A Amendment 2	3/24/2025 Event 3/20/2025
Deerfield Mgmt III, L.P.			5.4%	5,257,329
Deerfield Private Design Fund III, L.P.			5.4%	5,257,329
Deerfield Mgmt IV, L.P.			5.4%	5,257,328
Deerfield Private Design Fund IV, L.P.			5.4%	5,257,328
Deerfield Management Company, L.P.			10.7%	10,514,657
James E. Flynn			10.7%	10,514,657
BiomX Inc. 13D/A Amendment 3 PHGE · 09090D103	PHGE	09090D103	10.0%	15,558,445	13D/A Amendment 3	3/3/2025 Event 2/27/2025
Deerfield Private Design Fund V, L.P.			10.0%	7,779,222
Deerfield Mgmt V, L.P.			10.0%	7,779,222
Deerfield Healthcare Innovations Fund II, L.P.			10.0%	7,779,222
Deerfield Mgmt HIF II, L.P.			10.0%	7,779,222
Deerfield Management Company, L.P.			10.0%	15,558,445
James E. Flynn			10.0%	15,558,445
Singular Genomics Systems, Inc. 13D/A Amendment 3 OMIC · 82933R308	OMIC	82933R308	100.0%	1,000	13D/A Amendment 3	2/25/2025 Event 2/21/2025
Deerfield Mgmt IV, L.P.			100.0%	1,000
Deerfield Private Design Fund IV, L.P.			100.0%	1,000
Deerfield Management Company, L.P.			100.0%	1,000
James E. Flynn			100.0%	1,000
DocGo Inc. 13G/A Amendment 3 DCGO · 256086109	DCGO	256086109	4.95%	5,051,500	13G/A Amendment 3	2/13/2025 Event 2/13/2025
Deerfield Mgmt, L.P.			4.95%	5,051,500
Deerfield Management Company, L.P.			4.95%	5,051,500
Deerfield Partners, L.P.			4.95%	5,051,500
James E. Flynn			4.95%	5,051,500
Indivior PLC 13G/A Amendment 1 INDV · G4766E116	INDV	G4766E116	7.2%	8,883,160	13G/A Amendment 1	2/13/2025 Event 12/31/2024
Deerfield Mgmt, L.P.			7.2%	8,883,160
Deerfield Management Company, L.P.			7.2%	8,883,160
Deerfield Partners, L.P.			7.2%	8,883,160
James E. Flynn			7.2%	8,883,160
Ventyx Biosciences, Inc. 13G/A Amendment 2 VTYX · 92332V107	VTYX	92332V107	0.8%	534,737	13G/A Amendment 2	2/13/2025 Event 12/31/2024
Deerfield Mgmt, L.P.			0.8%	534,737
Deerfield Management Company, L.P.			0.8%	534,737
Deerfield Partners, L.P.			0.8%	534,737
James E. Flynn			0.8%	534,737
Prelude Therapeutics Incorporated 13G/A Amendment 2 PRLD · 74065P101	PRLD	74065P101	0%	0	13G/A Amendment 2	2/13/2025 Event 12/31/2024
Deerfield Mgmt, L.P.			0%	0
Deerfield Management Company, L.P.			0%	0
Deerfield Partners, L.P.			0%	0
James E. Flynn			0%	0
Kura Oncology, Inc. 13G/A Amendment 2 KURA · 50127T109	KURA	50127T109	0%	0	13G/A Amendment 2	2/13/2025 Event 12/31/2024
Deerfield Mgmt, L.P.			0%	0
Deerfield Management Company, L.P.			0%	0
Deerfield Partners, L.P.			0%	0
James E. Flynn			0%	0
Catalyst Pharmaceuticals, Inc. 13G/A Amendment 4 CPRX · 14888U101	CPRX	14888U101	2.6%	3,133,011	13G/A Amendment 4	2/13/2025 Event 12/31/2024
Deerfield Mgmt, L.P.			2.6%	3,133,011
Deerfield Management Company, L.P.			2.6%	3,133,011
Deerfield Partners, L.P.			2.6%	3,133,011
James E. Flynn			2.6%	3,133,011
Alignment Healthcare, Inc. 13G/A Amendment 1 ALHC · 01625V104	ALHC	01625V104	3.8%	7,304,302	13G/A Amendment 1	2/13/2025 Event 12/31/2024
Deerfield Mgmt, L.P.			3.8%	7,304,302
Deerfield Management Company, L.P.			3.8%	7,304,302
Deerfield Partners, L.P.			3.8%	7,304,302
James E. Flynn			3.8%	7,304,302
Nuvalent, Inc. 13G/A Amendment 5 NUVL · 670703107	NUVL	670703107	27.6%	23,582,278	13G/A Amendment 5	2/13/2025 Event 12/31/2024
Deerfield Management Company, L.P.			27.6%	23,582,278
Deerfield Mgmt IV, L.P.			13.2%	11,388,139
Deerfield Private Design Fund IV, L.P.			13.2%	11,388,139
Deerfield Mgmt HIF, L.P.			13.2%	11,388,139
Deerfield Healthcare Innovations Fund, L.P.			13.2%	11,388,139
Deerfield Mgmt, L.P.			1.0%	650,000
Deerfield Partners, L.P.			1.0%	650,000
James E. Flynn			27.6%	23,582,278
Acutus Medical, Inc. 13D/A Amendment 9 AFIB · 005111109	AFIB	005111109	9.1%	5,492,725	13D/A Amendment 9	1/28/2025 Event 1/27/2025
Deerfield Mgmt III, L.P.			5.4%	3,438,589
Deerfield Private Design Fund III, L.P.			5.4%	3,438,589
Deerfield Mgmt, L.P.			4.9%	1,974,638
Deerfield Partners, L.P.			4.9%	1,974,638
Deerfield Management Company, L.P.			9.1%	5,492,725
James E. Flynn			9.1%	5,492,725
Acutus Medical, Inc. 13D/A Amendment 8 AFIB · 005111109	AFIB	005111109	9.1%	9,705,857	13D/A Amendment 8	1/23/2025 Event 1/21/2025
Deerfield Mgmt III, L.P.			5.5%	5,731,096
Deerfield Private Design Fund III, L.P.			5.5%	5,731,096
Deerfield Mgmt, L.P.			4.9%	3,895,263
Deerfield Partners, L.P.			4.9%	3,895,263
Deerfield Management Company, L.P.			9.1%	9,705,857
James E. Flynn			9.1%	9,705,857
Singular Genomics Systems, Inc. 13D/A Amendment 2 OMIC · 82933R308	OMIC	82933R308	6.6%	249,495	13D/A Amendment 2	12/26/2024 Event 12/22/2024
Deerfield Mgmt IV, L.P.			6.6%	249,495
Deerfield Private Design Fund IV, L.P.			6.6%	249,495
Deerfield Management Company, L.P.			6.6%	249,495
James E. Flynn			6.6%	249,495

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.